Rhode Island 2025 Regular Session

Rhode Island Senate Bill S0467

Introduced
2/26/25  

Caption

Establishes the Wholesale Prescription Drug Importation Program for the importation of wholesale prescription drugs from Canada, to provide savings to Rhode Island consumers.

Impact

If enacted, the program would require the appointment of a state agency as a licensed drug wholesaler or the formation of contracts with existing licensed wholesalers to handle the importation. The proposed legislation allows for the only importation of drugs that meet the safety and effectiveness standards of the FDA, ensuring that health outcomes are not compromised while accessing lower-priced medications. The program is also set to start within six months of federal approval and certification, allowing it to benefit consumers promptly.

Summary

Bill S0467 establishes a Wholesale Prescription Drug Importation Program aimed at enabling the importation of prescription drugs from Canada. This initiative is intended to provide significant cost savings to consumers within Rhode Island. The bill outlines a framework for how the state can implement such a program, making it necessary for the state to secure federal approval from the U.S. Department of Health and Human Services before proceeding.

Reporting

The bill mandates annual reporting from the executive office of health and human services about the program's implementation, including details on the drugs imported, estimated cost savings achieved, and compliance with the created audit work plan. This requirement aims to maintain transparency and accountability, ensuring that the state's objectives in providing affordable access to prescription medication are being met effectively.

Contention

One notable point of contention surrounding S0467 lies in the existing regulations on drug importation and safety standards. Critics may question the safety and efficacy of drugs imported under this framework, regardless of adherence to FDA standards. Additionally, the implementation feasibility on a larger scale through multistate collaboration brings about discussions on regulatory challenges and the risk of discrepancies in drug coverage and availability across state lines. Supporters of the bill emphasize the potential financial savings for consumers as a primary benefit.

Companion Bills

No companion bills found.

Similar Bills

CA SB1361

Prescription drugs: cost sharing: pharmacy benefit managers.

CA AB458

Importation of prescription drugs.

HI HB14

Relating To Prescription Drugs.

HI SB319

Relating To Prescription Drugs.

NJ A2809

Permits import of Canadian prescription drugs.

FL H0283

Storage and Disposal of Prescription Drugs and Sharps

IL HB4525

PRESCRIPTION DRUG IMPORT ACT

IL HB1272

PRESCRIPTION DRUG IMPORT ACT